企業プロフィール
Incannex Healthcare 株価・ニュース・カタリスト
- ティッカー:
- IXHL
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Australia and listed in the U
株価パフォーマンス
3.31 USD (+1.07%)
終値
最終更新: 2026年8月17日
36.5M USD
時価総額
株価変動の要因
As of Aug 17, 2026, IXHL closed up 1.07% at $3.31. No new same-company headline was identified in the current news window.
企業概要
事業概要
Incannex Healthcare is a biotechnology company focused on cannabinoid-based and related therapies for inflammatory and sleep disorders. Its story is centered on translating cannabinoid science into specialty treatments.
所在地とセクター分類
Incannex is headquartered in Australia and listed in the U.S. market. It sits in specialty biotechnology with a cannabinoid and inflammation focus.
ビジネスモデルの特徴
The company depends on clinical data, regulatory progress, and capital efficiency while it develops a narrow pipeline. Investors watch early signals and commercialization potential.
バイオ業界での位置付け
Incannex occupies a niche cannabinoid-biotech position. The stock is catalyst-sensitive because the company still needs to prove its therapeutic thesis in the clinic.
今後のカタリスト
- Incannex’s catalysts are its cannabinoid / inflammatory-disease programs and any clinical step that keeps the platform alive. The stock remains highly event-driven.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。